2-(4-Bromo-3-methylphenyl)-5-methyl-1,3,4-oxadiazole → 6,2'-Dimethyl-4'-(5-methyl-[1,3,4]oxadiazol-2-yl)-biphenyl-3-carboxylic acid cyclopropylmethyl-amide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	2-(4-Bromo-3-methylphenyl)-5-methyl-1,3,4-oxadiazole	HCID 11436693	—
Edukt	N-cyclopropylmethyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide	HCID 21914588	—
Produkt	6,2'-Dimethyl-4'-(5-methyl-[1,3,4]oxadiazol-2-yl)-biphenyl-3-carboxylic acid cyclopropylmethyl-amide	HCID 10067151	—

Reaktionsschritte

The title compound was prepared using 2-(4-bromo-3-methylphenyl)-5-methyl-[1,3,4]oxadiazole and N-cyclopropylmethyl-4-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)benzamide (Intermediate 17).

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US07425555B2
Quelldatensatz	uspto-grants-2008_09
ORD ID	ord-087df855699d41b6b593c6299ddb8f65
Quellennotiz	uspto-grants-2008_09